Clamor for GSK shingles shot points to bigger profits Ruby Khatun Khatun26 Jun 2018 10:00 AM ISTLONDON: GlaxoSmithKline (GSK) is facing “unprecedented” demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger...
Pfizer's breast cancer drug combo falls short of survival goal Ruby Khatun Khatun26 Jun 2018 9:45 AM ISTPfizer Inc said a combination of its breast cancer drug, Ibrance, and another drug was not statistically significant in extending overall survival in...
Study preserves hopes for Roche's Tecentriq in lung cancer Ruby Khatun Khatun26 Jun 2018 9:30 AM ISTZURICH: Swiss drugmaker Roche’s hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form of lung...
Biocon receives EIR from USFDA for its Bengaluru facility producing sterile Ruby Khatun Khatun25 Jun 2018 3:04 PM ISTNew Delhi: Biotechnology firm Biocon said it has received Establishment Inspection Report (EIR) from the US health regulator on the closure of...
Dr Reddy's loses patent case with Eli Lilly over Alimta Ruby Khatun Khatun25 Jun 2018 10:30 AM ISTDr Reddy's Laboratories Limited has lost a legal battle with Eli Lilly and Company in a patent litigation on Alimta (pemetrexed for injection), a drug...
Lupin to launch nearly 30 products in US market in FY18 Ruby Khatun Khatun25 Jun 2018 10:00 AM ISTNew Delhi: With rapid approvals from US health regulator anticipated, homegrown drug major Lupin sees the opportunity to launch around 30 generic...
Genkyotex expands license agreement for Vaxiclase platform with Serum Institute of India Ruby Khatun Khatun25 Jun 2018 9:45 AM ISTGenkyotex, a biopharmaceutical company and the leader in NOX therapies, announces that it has expanded the license agreement for its Vaxiclase...
US medical device firm electroCore IPO price set at 15 dollar per share Ruby Khatun Khatun25 Jun 2018 9:30 AM ISTU.S. medical device maker electroCore Inc’s initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told...
Unichem to pay 5 percent royalty to Eli Lilly for generic tadalafil till Apr 2020 Ruby Khatun Khatun24 Jun 2018 10:30 AM ISTNew Delhi: Drug firm Unichem Laboratories said it will pay Eli Lilly a royalty of 5 percent on the net sales of the generic tadalafil product till the...
FDA permits marketing of first catheter-based systems for hemodialysis patients Ruby Khatun Khatun24 Jun 2018 10:30 AM ISTThe U.S. Food and Drug Administration (FDA) permitted marketing of two catheter-based devices designed to create a connection to veins and arteries in...
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting Ruby Khatun Khatun24 Jun 2018 10:15 AM ISTLONDON: GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world’s leading AIDS conference next month by...
US District Court rules in favor of Lilly's Alimta patent Ruby Khatun Khatun24 Jun 2018 9:45 AM ISTEli Lilly and Co said a U.S. District Court ruled in favor of its patent on Alimta vitamin regimen and prevented Hospira Inc and India’s Dr. Reddy’s...
